Elis' Share Capital and Voting Rights Overview for Stakeholders

Elis' Insights on Share Capital and Voting Rights
In the world of finance and investments, staying informed about a company's capital structure and voting rights is crucial. For stakeholders of Elis, knowing the number of shares and the total voting rights is vital for understanding their position and influence within the company.
Understanding Share Capital
As of a recent reporting date, the total number of shares forming the share capital of Elis stands at 236,664,445 shares. This figure provides insight into the ownership and distribution of equity among shareholders in the company.
The Importance of Share Capital
Share capital is essentially the financial backbone of a corporation. It reflects how much money is invested by the shareholders and determines the proportionate ownership of each shareholder within the company. A larger share capital can mean a more stable company, providing a cushion for economic fluctuations.
Voting Rights Explained
Recognizing the number of voting rights is equally important. The theoretical number of voting rights at Elis is reported to be 281,450,493. This number indicates how many votes shareholders collectively possess, impacting their ability to influence corporate decisions.
Exercisable Voting Rights
Among these, the number of exercisable voting rights stands at 278,459,967. This means that not all theoretical voting rights may be exercised, which can impact decision-making during annual general meetings and other crucial shareholder votes.
Where to Find More Information
Elis is dedicated to transparency, making this crucial information available through their official channels. Shareholders can find these disclosures on the company’s website, helping them to stay up-to-date with significant changes that may affect their investments.
Contacts for Further Inquiries
For those who wish to delve deeper or require further clarification, Elis provides a direct line to their Investor Relations team. Nicolas Buron, the Director of Investor Relations, can be reached at +33 1 75 49 98 30, and Charline Lefaucheux is available at +33 1 75 49 98 15. Both can assist with inquiries regarding financial performance or shareholder matters.
Frequently Asked Questions
What is the total number of shares for Elis?
The total number of shares forming the share capital of Elis is 236,664,445.
How many theoretical voting rights does Elis have?
Elis possesses a theoretical number of voting rights equal to 281,450,493.
What are exercisable voting rights?
Exercisable voting rights for Elis are reported at 278,459,967, which can be used in shareholder votes.
Where can I find more information on Elis’ financials?
Further information can be found on the official Elis website, where disclosures and financial reports are published.
Who should I contact for Investor Relations?
You can contact Nicolas Buron or Charline Lefaucheux, both in the Investor Relations team at Elis, for additional inquiries.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.